Evidence map›Paper›PMID 37679838›Full record

ArticleAnnals of clinical microbiology and antimicrobials2023

Face mask sampling (FMS) for tuberculosis shows lower diagnostic sensitivity than sputum sampling in Guinea.

Souleymane Hassane-Harouna, Sofie Marijke Braet, Tom Decroo, Lansana Mady Camara, Alexandre Delamou, Sven de Bock, Nimer Ortuño-Gutiérrez, Gba-Foromo Cherif, Caroline M Williams, Anika Wisniewska and 3 more

Abstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Closing gaps through innovation in the tuberculosis pathology value chain.Journal of clinical tuberculosis and other mycobacterial diseases · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Souleymane Hassane-HarounaAction Damien Conakry, Conakry, Guinea. hassoul20@yahoo.fr.
Sofie Marijke BraetResearch Foundation Flanders, Brussels, Belgium.
Tom DecrooUnit of HIV & Co-infections, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Lansana Mady CamaraGamal Abdel Nasser University, Conakry, Guinea.
Alexandre DelamouGamal Abdel Nasser University, Conakry, Guinea.
Sven de BockUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Nimer Ortuño-GutiérrezDamien Foundation, Brussels, Belgium.
Gba-Foromo CherifAction Damien Conakry, Conakry, Guinea.
Caroline M WilliamsDepartment of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
Anika WisniewskaDepartment of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
Michael R BarerDepartment of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
Leen RigoutsUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Bouke Catherine de JongUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Funding

Medical Research Council MR/T031255/1
6 · The paper itself

Abstract

backgroundPulmonary tuberculosis (PTB) diagnosis relies on sputum examination, a challenge in sputum-scarce patients. Alternative non-invasive sampling methods such as face mask sampling (FMS) have been proposed.

objectiveTo evaluate the value of FMS for PTB diagnosis by assessing its agreement with sputum samples processed by GeneXpert MTB/RIF (Ultra)(Xpert) testing, and describe FMS sensitivity and specificity.

methodsThis was a prospective study conducted at the Carrière TB clinic in Guinea. Presumptive TB patients willing to participate were asked to wear a surgical mask containing a polyvinyl alcohol (PVA) strip for thirty minutes. Subsequently, two spot sputum samples were collected, of which one was processed by microscopy on site and the other by Xpert in Guinea's National Reference Laboratory of Mycobacteriology (LNRM). The first 30 FMS were processed at the Supranational Reference Laboratory in Antwerp, Belgium, and the following 118 FMS in the LNRM.

resultsOne hundred fifty patients participated, of whom 148 had valid results for both mask and sputum. Sputum smear microscopy was positive for 47 (31.8%) patients while sputum-Xpert detected MTB in 54 (36.5%) patients. Among the 54 patients testing sputum-Xpert positive, 26 (48.1%) yielded a positive FMS-Xpert result, while four sputum-Xpert negative patients tested positive for FMS and 90 patients were Xpert-negative for both sputum and mask samples, suggesting a moderate level of agreement (k-value of 0.47). The overall mask sensitivity was 48.1%, with 95.7% specificity.

conclusionIn our setting, Xpert testing on FMS did not yield a high level of agreement to sputum sample.

Indexed as

TuberculosisTuberculosis, PulmonaryGuineaHumansMasksProspective StudiesSputumFace mask samplingGuineaPulmonary tuberculosis

Identifiers

PMID37679838
PMCPMC10486030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.